Artificial intelligence in clinical genetics: Current practice and attitudes among the clinical genetics workforce.
Where this comes from
- Record sourced from PubMed, PMID 42429101.
- Also identified by DOI 10.1016/j.gim.2026.102645 and PMC identifier 13379928.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Because clinical genetics artificial intelligence (AI) applications and capabilities are on a rapid rise, this study sought to assess workforce readiness. To assess the workforce's use, knowledge, and attitudes about medical AI applications, we conducted a survey of 215 US-based genetics clinicians and trainees. More than half (51.2%) of participants reported little to no knowledge of AI in clinical genetics; 64.3% reported no formal training. Formal training correlated with greater self-reported knowledge of AI in clinical genetics: 69.3% of respondents with formal training (vs 37.5% without) reported intermediate to extensive knowledge of AI. Most participants reported insufficient knowledge of clinical AI (83.4%), desired more education (97.6%), and would take available training (89.3%). The majority (51.6%) of clinician participants initially reported not using AI applications in the clinic. However, after a tutorial describing clinical AI applications, 75.8% reported some use. When asked about specific applications, the majority of clinician participants used facial diagnostic applications (54.9%) and AI-generated genomic testing results (62.1%); other applications, such as chatbots, large language models, pedigree or medical summary generators, and risk assessment, were less commonly used (11.1%-12.5%). Further education is both desired and needed to optimally use AI applications in clinical genetics.